Literature DB >> 3966464

Monitoring of intensive phlebotomy therapy in iron overload by serum ferritin assay.

B A van Oost, B van den Beld, B S van Asbeck, J J Marx.   

Abstract

Four patients with idiopathic hemochromatosis were treated with intensive phlebotomy therapy. In 1 to 2 years, 8.8-16.7 g iron was removed. In three out of four patients hemoglobin levels fell at the end of therapy. Serum ferritin was continuously measured during therapy. The greatly elevated serum ferritin levels normalized or decreased to subnormal levels in all patients after therapy. Despite some fluctuations in the first phase of therapy, the fall in serum ferritin was regular with halving of the ferritin levels after about 50% of the excess iron was removed. The normalization of serum ferritin occurred in advance of the hemoglobin decrease at the end of therapy, indicating that in the later stages of therapy the normal iron stores are also depleted. It is emphasized that serum ferritin measurements are useful for monitoring of intensive phlebotomy therapy, and in particular to indicate the end of therapy before anemia develops.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3966464     DOI: 10.1002/ajh.2830180103

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  5 in total

Review 1.  Plasma ferritin determination as a diagnostic tool.

Authors:  C A Finch; V Bellotti; S Stray; D A Lipschitz; J D Cook; M J Pippard; H A Huebers
Journal:  West J Med       Date:  1986-11

Review 2.  METABOLISM OF IRON STORES.

Authors:  Hiroshi Saito
Journal:  Nagoya J Med Sci       Date:  2014-08       Impact factor: 1.131

3.  Determination of ferritin and hemosiderin iron in patients with normal iron stores and iron overload by serum ferritin kinetics.

Authors:  Hiroshi Saito; Akihiro Tomita; Haruhiko Ohashi; Hideaki Maeda; Hisao Hayashi; Tomoki Naoe
Journal:  Nagoya J Med Sci       Date:  2012-02       Impact factor: 1.131

4.  Increasing and decreasing phases of ferritin and hemosiderin iron determined by serum ferritin kinetics.

Authors:  Hiroshi Saito; Hisao Hayashi; Akihiro Tomita; Haruhiko Ohashi; Hideaki Maeda; Tomoki Naoe
Journal:  Nagoya J Med Sci       Date:  2013-08       Impact factor: 1.131

5.  Transformation rate between ferritin and hemosiderin assayed by serum ferritin kinetics in patients with normal iron stores and iron overload.

Authors:  Hiroshi Saito; Hisao Hayashi
Journal:  Nagoya J Med Sci       Date:  2015-11       Impact factor: 1.131

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.